Abstract Number: 243 • 2019 ACR/ARP Annual Meeting
Concomitant Fibromyalgia in Patients with Other Rheumatic Diseases and Response to Treatment
Background/Purpose: Some rheumatic disease patients have concomitant fibromyalgia. We wanted to determine treatment response in patients with and without concomitant fibromyalgia.Methods: Patients were diagnosed by…Abstract Number: 218 • 2019 ACR/ARP Annual Meeting
Effects of Tai Chi versus Aerobic Exercise on Mindfulness in Fibromyalgia
Background/Purpose: Emerging evidence shows that Tai Chi mind–body practice may result in greater benefits in pain and psychological symptoms of Fibromyalgia (FM). Mindfulness is the…Abstract Number: 448 • 2019 ACR/ARP Annual Meeting
Central Sensitization in Patients with Rheumatoid Arthritis Using the Central Sensitization Inventory
Background/Purpose: Pain of rheumatoid arthritis (RA) is thought to be nociceptive. However, recent studies indicate that RA pain also includes the mechanism of central sensitization…Abstract Number: 219 • 2019 ACR/ARP Annual Meeting
A Fibromyalgia Assessment Screening Tool on a Multidimensional Health Assessment Questionnaire (MDHAQ) Which Does Not Include a Self-Report RADAI Painful Joint Count (RADAI), FAST3nJC, Recognizes Fibromyalgia Similarly to Other FAST3 Indices Which Include a RADAI
Background/Purpose: Fibromyalgia (FM) generally is easily recognized, but a diagnosis may be difficult, particularly in patients with secondary FM who have other primary diagnoses. Criteria…Abstract Number: 683 • 2019 ACR/ARP Annual Meeting
Biologic Differences Between Type 1 and 2 Lupus
Background/Purpose: The manifestations of systemic lupus erythematosus (SLE) can be divided into categories according to a recently proposed model: a category of classic active autoimmune-driven…Abstract Number: 220 • 2019 ACR/ARP Annual Meeting
A Positive Response to Nonpharmacological Therapies in Patients with Fibromyalgia
Background/Purpose: Identifying the factors associated with response to nonpharmacological therapies in patients with fibromyalgia will help personalize treatments and provide information to improve the design…Abstract Number: 827 • 2019 ACR/ARP Annual Meeting
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial of Bedtime Sublingual Cyclobenzaprine (TNX-102 SL) for the Treatment of Fibromyalgia (FM): Evidence for a Broad Spectrum of Activity on the FM Syndrome
Background/Purpose: Fibromyalgia (FM) is characterized by chronic widespread pain, unrefreshing sleep, fatigue, and cognitive complaints. TNX-102 SL* is a sublingual (SL) formulation of cyclobenzaprine (CBP)…Abstract Number: 223 • 2019 ACR/ARP Annual Meeting
Correlation Between Heart Rate Variability Parameters and Circulating Neuropeptides in Fibromyalgia
Background/Purpose: Heart rate variability analyses in fibromyalgia patients have shown changes consistent with sympathetic hyperactivity that theoretically could lead to chronic pain. There is little…Abstract Number: 828 • 2019 ACR/ARP Annual Meeting
A Path Model Analysis of the Cognitive Determinants of Physical Activity Among Patients with Fibromyalgia (FM)
Background/Purpose: In individuals with FM, regular participation in physical activity (PA) is associated with improvement of symptoms, daily physical functioning, and overall well-being. Given the…Abstract Number: 224 • 2019 ACR/ARP Annual Meeting
A Functional Exercise Program Improves Pain and Health Related Quality of Life in Patients with Fibromyalgia: A Randomized Controllel Trial
Background/Purpose: Fibromyalgia (FM) is a syndrome characterized mainly by chronic generalized pain that affects the physical fitness and functional capacity of patients. There is increasing…Abstract Number: 829 • 2019 ACR/ARP Annual Meeting
Dietary Intake Does Not Explain Microbiome Alterations or Symptom Severity in Fibromyalgia
Background/Purpose: We have recently reported significant alterations in gut microbiome compositionin women with fibromyalgia (FM). As gut microbiome is affected by diet, differences in nutritional…Abstract Number: 225 • 2019 ACR/ARP Annual Meeting
Evaluating Fibromyalgia Symptoms in Transgender Patients
Background/Purpose: Fibromyalgia Syndrome (FMS), characterized by widespread pain and fatigue, is known to be more prevalent in women, and has frequently been associated with stress…Abstract Number: 830 • 2019 ACR/ARP Annual Meeting
The Efficacy of Non-Pharmacological Interventions for Fibromyalgia: A Systematic Review with Meta-Analysis
Background/Purpose: Non-pharmacological interventions are recommended as first-line treatment for fibromyalgia (FM)1. However, the evidence base supporting this has not been updated comprehensively, and the recent…Abstract Number: 226 • 2019 ACR/ARP Annual Meeting
Hypersensitivity Beyond Pain: Hyperacusis and Hyperalgesia of Patients with Fibromyalgia
Background/Purpose: Fibromyalgia (FM) is a condition in which patients are afflicted with unexplained chronic musculoskeletal pain, insomnia and fatigue. The underlying mechanisms of this disorder…Abstract Number: 831 • 2019 ACR/ARP Annual Meeting
Maintaining Musculoskeletal Health: A Randomized Controlled Prevention Trial Amongst People at High Risk of Developing Chronic Widespread Pain
Background/Purpose: Cognitive behaviour therapy (CBT) is effective in the management of fibromyalgia (and its characteristic feature Chronic Widespread Pain (CWP). CBT is recommended in all…
- « Previous Page
- 1
- …
- 9
- 10
- 11
- 12
- 13
- …
- 25
- Next Page »